Table 2.
QTLs for resistances to ELS and LLS diseases in different locations and years.
| Trait | QTL name | Linkage group | PVE (%) | Confidence interval (cM) | Additive effect |
|---|---|---|---|---|---|
| LLS-2015 | qLLS2015-A05 | A05 | 5.26 | 177.7–178.7 | 0.26 |
| qLLS2015-B05-1 | B05 | 5.03 | 3.2–10.3 | 0.26 | |
| qLLS2015-B05-2 | B05 | 11.64 | 136.1–142.3 | 0.30 | |
| LLS-2016 | qLLS2016-A02 | A02 | 7.36 | 63.9–64.3 | 0.34 |
| qLLS2016-A07 | A07 | 6.53 | 208.2–210.8 | 0.32 | |
| qLLS2016-A09 | A09 | 6.95 | 143.8–144.6 | 0.32 | |
| qLLS2016-B01 | B01 | 9.86 | 97.9–102.9 | 0.36 | |
| qLLS2016-B05 | B05 | 16.60 | 137.2–143.0 | 0.39 | |
| ELS-2016 | qELS2016-A03 | A03 | 7.59 | 99.4–100.4 | 0.25 |
| qELS2016-A07 | A07 | 6.40 | 157.8–158.8 | 0.25 | |
| qELS2016-B04 | B04 | 10.63 | 94.8–102.0 | 0.32 | |
| qELS2016-B10 | B10 | 8.15 | 75.6–76.0 | 0.25 | |
| ELS-2017 | qELS2017-A03-1 | A03 | 7.00 | 87.6–88.7 | 0.26 |
| qELS2017-A03-2 | A03 | 11.67 | 163.7–168.4 | 0.28 | |
| qELS2017-A07 | A07 | 4.93 | 64.8–65.6 | 0.25 |